Gelteq GELS
NASDAQ GELS
$0.58 +0.03 (+5.42%)
At close: Aug 20, 2026 · 2:59 PM UTC

Gelteq (GELS) Change in Cash (2023 - 2025)

Gelteq (GELS) posted quarterly Change in Cash of -$21.3 million for Q4 2025, down 11891.12% quarter-over-quarter from -$177355.8 in Q4 2023.

Gelteq (GELS) Change in Cash (2023 - 2025) Analysis & Trends

Gelteq's Change in Cash history runs 2 years deep, the most recent figure standing at -$21.3 million for Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Haleon 43.86 Bn 42.90 Bn - -
2 Teva Pharmaceutical Industries 43.19 Bn 39.54 Bn 2.15 Bn -86.00 Mn
3 Zoetis 31.46 Bn 29.79 Bn 1.05 Bn -465.00 Mn
4 Takeda Pharmaceutical 28.57 Bn 22.77 Bn 5.10 Bn -881.03 Mn
5 United Therapeutics 22.15 Bn 19.49 Bn 683.80 Mn 523.50 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -915.70 Mn
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn 64.40 Mn
8 Elanco Animal Health 11.71 Bn 11.18 Bn 798.00 Mn 102.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - -
10 Gelteq 6.08 Mn 5.81 Mn - -21.27 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -21.27 Mn
Dec 31, 2023 -177,355.85